Physicochemical Properties
| Molecular Formula | C14H7BRCLNO2 |
| Molecular Weight | 336.57 |
| Exact Mass | 334.934 |
| CAS # | 1234707-32-4 |
| PubChem CID | 46838144 |
| Appearance | Typically exists as solid at room temperature |
| Density | 1.7±0.1 g/cm3 |
| Boiling Point | 436.9±38.0 °C at 760 mmHg |
| Flash Point | 218.0±26.8 °C |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.682 |
| LogP | 4.16 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Heavy Atom Count | 19 |
| Complexity | 401 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | WXWVDINGZQKMMS-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C14H7BrClNO2/c15-9-5-2-1-4-8(9)13-17-11-7-3-6-10(16)12(11)14(18)19-13/h1-7H |
| Chemical Name | 2-(2-bromophenyl)-5-chloro-3,1-benzoxazin-4-one |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vivo | Neutrophil elastase inhibitor 3 (compound 13, 1 mg/kg of body weight, intravenous administration) significantly reduced the increase in pulmonary myeloperoxidase (MPO) activity and edema after traumatic hemorrhagic shock in rats. |
| References |
[1]. Synthesis and evaluation of benzoxazinone derivatives on activity of human neutrophil elastase and on hemorrhagic shock-induced lung injury in rats. Eur J Med Chem. 2010 Jul;45(7):3111-5. |
Solubility Data
| Solubility (In Vitro) | May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples |
| Solubility (In Vivo) | Solubility in formula 1: (Saturation unknown) in Neutrophil elastase inhibitor 3 (compound 13) is dissolved in 10% DMSO[1]. (These co-solvents are added one by one from left to right). (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.9712 mL | 14.8558 mL | 29.7115 mL | |
| 5 mM | 0.5942 mL | 2.9712 mL | 5.9423 mL | |
| 10 mM | 0.2971 mL | 1.4856 mL | 2.9712 mL |